NEW YORK--(BUSINESS WIRE)-- Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announces that effective today, Mr. Igor Gimelshtein will be transitioning from his role as an Independent Director to a Board Observer position.
“On behalf of the entire Board of Directors, I wish to thank Igor for his contributions and guidance over the past several years, particularly as we transitioned to the public markets,” said Michael Abbott, Executive Chairman of Columbia Care. “I am also delighted that Igor will remain engaged and involved as a Board Observer, so that the Company can continue to benefit from his broad industry knowledge.”
Added Mr. Gimelshtein, “It has been a pleasure to work so closely with the Board of Directors and management team of Columbia Care. I am proud of what we have accomplished together and believe strongly in what the Company has built and will achieve. I am very much looking forward to continuing our work together as a Board Observer and providing on-going support and advice."
As a result of Mr. Gimelshtein’s transition, the nominees for election to Columbia Care’s Board of Directors at its Annual Meeting of Shareholders are:
01 – Nicholas Vita
02 – Michael Abbott
03 – Frank Savage
04 – James A.C. Kennedy
05 – Jonathan P. May
06 – Jeff Clarke
Annual Meeting of Shareholders and Webcast Details
This year, out of an abundance of caution, to proactively deal with the public health impact of the recent Coronavirus outbreak, also known as COVID-19, and to mitigate the risks to the health and safety of our communities, Shareholders, employees and other stakeholders, we will hold the Meeting in a virtual only format, which will be conducted via live audio webcast.
The Meeting will be held on Monday, June 8th, 2020 at 3:45 p.m. EDT and can be accessed online at https://web.lumiagm.com/298550642 .
About Columbia Care Inc.
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 18 US jurisdictions1 and the EU. Columbia Care has completed more than 1.8 million sales transactions since inception and working in collaboration with renowned and innovative teaching hospitals and medical centers globally, continues to be a patient-centered health and wellness company setting the standard for compassion, professionalism, quality, care and innovation in the rapidly expanding cannabis industry. For more information on Columbia Care, please visit www.col-care.com.
1 Includes Colorado, subject to successful completion of the acquisition of The Green Solution and W. Virginia industrial hemp cultivation license
Gary F. Santo, Jr.
Source: Columbia Care Inc.
Released June 8, 2020